Oxford Spin-out Promises Inexpensive Vaccines for Cancer and Viral Infections
A spin-out from the University of Oxford, Oxford Vacmedix, will commercialise a new technology with the potential to reduce the cost of vaccine development significantly and increase the effectiveness of vaccines in providing immunity against both infectious diseases and cancer. The technology makes use of techniques that have already produced effective vaccines under laboratory conditions.